Financhill
Back

Aligos Therapeutics Stock Price Chart

  • The current trend is relatively stagnant and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

Aligos Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 34.37 Sell
20-day SMA: 37.9 Sell
50-day SMA: 28.75 Buy
200-day SMA: 17.48 Buy
8-day EMA: 34.42 Sell
20-day EMA: 35.21 Sell
50-day EMA: 29.79 Buy
200-day EMA: 20.62 Buy

Aligos Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.91 Buy
Relative Strength Index (14 RSI): 50.11 Buy
Chaikin Money Flow: 205786 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.96 - 41.26) Sell
Bollinger Bands (100): (7.59 - 31.23) Buy

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Aligos Therapeutics Stock

Is Aligos Therapeutics Stock a Buy?

ALGS Technical Analysis vs Fundamental Analysis

Sell
44
Aligos Therapeutics (ALGS) is a Sell

Is Aligos Therapeutics a Buy or a Sell?

Aligos Therapeutics Stock Info

Market Cap:
122.8M
Price in USD:
34.24
Share Volume:
221.4K

Aligos Therapeutics 52-Week Range

52-Week High:
46.80
52-Week Low:
6.76
Sell
44
Aligos Therapeutics (ALGS) is a Sell

Aligos Therapeutics Share Price Forecast

Is Aligos Therapeutics Stock a Buy?

  • Aligos Therapeutics share price is 34.24 while ALGS 8-day exponential moving average is 34.42, which is a Sell signal.
  • The stock price of ALGS is 34.24 while Aligos Therapeutics 20-day EMA is 35.21, which makes it a Sell.
  • Aligos Therapeutics 50-day exponential moving average is 29.79 while ALGS share price is 34.24, making it a Buy technically.
  • ALGS stock price is 34.24 and Aligos Therapeutics 200-day simple moving average is 20.62, creating a Buy signal.

Fundamental Analysis of Aligos Therapeutics

Is Aligos Therapeutics a good investment?

  • Analysts estimate an earnings decrease this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.65 per share, and a decrease next year of $0.14 per share.

Technical Analysis of Aligos Therapeutics

Should I short Aligos Therapeutics stock?

* Aligos Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.